STERIS plc Interest Expense
STERIS plc (STE) reported Interest Expense of $30.38 million for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-08-08
- STERIS plc interest expense for the quarter ending 2024-06-30 was $30.38M, a 6.10% decline year-over-year.
- STERIS plc interest expense for the quarter ending 2024-03-31 was $36.10M, a 17.98% increase year-over-year.
- STERIS plc interest expense for the quarter ending 2023-12-31 was $38.95M, a 36.37% increase year-over-year.
- STERIS plc interest expense for the quarter ending 2023-09-30 was $36.94M, a 41.41% increase year-over-year.
- STERIS plc interest expense for fiscal 2024 was $144.35M, a 33.71% increase from fiscal 2023.
- STERIS plc interest expense for fiscal 2023 was $107.96M, a 20.63% increase from fiscal 2022.
- STERIS plc interest expense for fiscal 2022 was $89.49M, a 140.69% increase from fiscal 2021.
- STERIS plc interest expense for fiscal 2021 was $37.18M, a 7.69% decline from fiscal 2020.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|
| 2024-06-30 | $30.38M 10-Q · filed 2024-08-08 | $66.49M derived: sum of 2 quarters · filed 2024-08-08 | $105.43M derived: sum of 3 quarters · filed 2024-08-08 | $142.37M derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2024-03-31 | $36.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-29 | $75.05M derived: sum of 2 quarters · filed 2024-05-29 | $111.99M derived: sum of 3 quarters · filed 2024-05-29 | $144.35M 10-K · filed 2024-05-29 | ||
| 2023-12-31 | $38.95M 10-Q · filed 2024-02-08 | $75.89M derived: sum of 2 quarters · filed 2024-02-08 | $108.25M 10-Q · filed 2024-02-08 | $138.84M derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-09-30 | $36.94M 10-Q · filed 2023-11-07 | $69.30M 10-Q · filed 2023-11-07 | $99.90M derived: sum of 3 quarters · filed 2024-08-08 | $128.46M derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-06-30 | $32.36M 10-Q · filed 2024-08-08 | $32.36M 10-Q · filed 2023-08-08 | $62.96M derived: sum of 2 quarters · filed 2024-08-08 | $91.52M derived: sum of 3 quarters · filed 2024-08-08 | $117.64M derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | $30.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-29 | $59.16M derived: sum of 2 quarters · filed 2024-05-29 | $85.28M derived: sum of 3 quarters · filed 2024-05-29 | $107.96M 10-K · filed 2024-05-29 | $107.99M 10-K · filed 2023-05-26 | |
| 2022-12-31 | $28.56M 10-Q · filed 2024-02-08 | $54.68M derived: sum of 2 quarters · filed 2024-02-08 | $77.36M 10-Q · filed 2024-02-08 | $99.03M derived: sum of 4 quarters · filed 2024-05-29 | ||
| 2022-09-30 | $26.12M 10-Q · filed 2023-11-07 | $48.80M 10-Q · filed 2023-11-07 | $70.47M derived: sum of 3 quarters · filed 2024-05-29 | $93.44M derived: sum of 4 quarters · filed 2024-05-29 | ||
| 2022-06-30 | $22.67M 10-Q · filed 2023-08-08 | $44.34M derived: sum of 2 quarters · filed 2024-05-29 | $67.31M derived: sum of 3 quarters · filed 2024-05-29 | $90.35M derived: sum of 4 quarters · filed 2024-05-29 | ||
| 2022-03-31 | $21.67M derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-29 | $44.64M derived: sum of 2 quarters · filed 2024-05-29 | $67.68M derived: sum of 3 quarters · filed 2024-05-29 | $89.49M 10-K · filed 2024-05-29 | $89.59M 10-K · filed 2022-05-31 | |
| 2021-12-31 | $22.97M 10-Q · filed 2023-02-08 | $46.01M derived: sum of 2 quarters · filed 2023-02-08 | $67.82M 10-Q · filed 2023-02-08 | $77.94M derived: sum of 4 quarters · filed 2023-05-26 | ||
| 2021-09-30 | $23.04M 10-Q · filed 2022-11-09 | $44.85M 10-Q · filed 2022-11-09 | $54.97M derived: sum of 3 quarters · filed 2023-05-26 | $63.87M derived: sum of 4 quarters · filed 2023-05-26 | ||
| 2021-06-30 | $21.81M 10-Q · filed 2022-08-08 | $31.94M derived: sum of 2 quarters · filed 2023-05-26 | $40.84M derived: sum of 3 quarters · filed 2023-05-26 | $49.50M derived: sum of 4 quarters · filed 2023-05-26 | ||
| 2021-03-31 | $10.12M derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-26 | $19.02M derived: sum of 2 quarters · filed 2023-05-26 | $27.69M derived: sum of 3 quarters · filed 2023-05-26 | $37.18M 10-K · filed 2023-05-26 | ||
| 2020-12-31 | $8.90M 10-Q · filed 2022-02-09 | $17.56M derived: sum of 2 quarters · filed 2022-02-09 | $27.06M 10-Q · filed 2022-02-09 | $36.63M derived: sum of 4 quarters · filed 2022-05-31 | ||
| 2020-09-30 | $8.66M 10-Q · filed 2021-11-08 | $18.16M 10-Q · filed 2021-11-08 | $27.73M derived: sum of 3 quarters · filed 2022-05-31 | $37.55M derived: sum of 4 quarters · filed 2022-05-31 | ||
| 2020-06-30 | $9.49M 10-Q · filed 2021-08-09 | $19.07M derived: sum of 2 quarters · filed 2022-05-31 | $28.88M derived: sum of 3 quarters · filed 2022-05-31 | $39.33M derived: sum of 4 quarters · filed 2022-05-31 | ||
| 2020-03-31 | $9.58M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31 | $19.39M derived: sum of 2 quarters · filed 2022-05-31 | $29.83M derived: sum of 3 quarters · filed 2022-05-31 | $40.28M 10-K · filed 2022-05-31 | ||
| 2019-12-31 | $9.81M 10-Q · filed 2021-02-09 | $20.26M derived: sum of 2 quarters · filed 2021-02-09 | $30.70M 10-Q · filed 2021-02-09 | $41.70M derived: sum of 4 quarters · filed 2021-05-28 | ||
| 2019-09-30 | $10.44M 10-Q · filed 2020-11-06 | $20.89M 10-Q · filed 2020-11-06 | $31.89M derived: sum of 3 quarters · filed 2021-05-28 | $42.77M derived: sum of 4 quarters · filed 2021-05-28 | ||
| 2019-06-30 | $10.45M 10-Q · filed 2020-08-07 | $21.45M derived: sum of 2 quarters · filed 2021-05-28 | $32.33M derived: sum of 3 quarters · filed 2021-05-28 | $43.72M derived: sum of 4 quarters · filed 2021-05-28 | ||
| 2019-03-31 | $11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-28 | $21.88M derived: sum of 2 quarters · filed 2021-05-28 | $33.27M derived: sum of 3 quarters · filed 2021-05-28 | $45.02M 10-K · filed 2021-05-28 | ||
| 2018-12-31 | $10.88M 10-Q · filed 2020-02-10 | $22.27M derived: sum of 2 quarters · filed 2020-02-10 | $34.01M 10-Q · filed 2020-02-10 | |||
| 2018-09-30 | $11.39M 10-Q · filed 2019-11-07 | $23.13M 10-Q · filed 2019-11-07 | ||||
| 2018-06-30 | $11.74M 10-Q · filed 2019-08-07 | |||||
| 2018-03-31 | $50.63M 8-K · filed 2021-02-09 | |||||
| 2017-03-31 | $44.52M 10-K · filed 2019-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |